“HATSUNE MIKU LIGHTS TOKYO” Debuts on July 25
4.8.2026 09:00:00 CEST | Business Wire | Press Release
The Tokyo Metropolitan Government has been presenting year-round projection mapping displays on the Tokyo Metropolitan Government Building, using light and sound to showcase a wide range of artistic expressions as part of its efforts to create new nighttime tourism attractions in Tokyo.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260802298570/en/
© Crypton Future Media, INC.
On Saturday, July 25, "HATSUNE MIKU LIGHTS TOKYO", featuring the globally beloved virtual singer Hatsune Miku, held its first screening. The work brings the world of the popular song “M@GICAL☆CURE! LOVE ♥ SHOT!” to life across the entire façade of the Tokyo Metropolitan Government Building. Since its launch in February 2024, “TOKYO Night & Light” has welcomed visitors from Japan and around the world, with total attendance surpassing 1.55 million.
As one of Tokyo’s emerging landmark attractions, the project continues to captivate audiences through its combination of artistic excellence, cutting-edge technology, and world-class content. We look forward to your continued interest and support.
Scenes from the Premiere of “HATSUNE MIKU LIGHTS TOKYO”
6,700 Visitors on Opening Weekend
On the opening weekend of HATSUNE MIKU LIGHTS TOKYO, approximately 6,700 visitors came to Tokyo Metropolitan Government Plaza, including tourists from Japan and overseas.
Many people gathered at the plaza even before the screenings began, creating a lively atmosphere full of anticipation. Some visitors shared their excitement, saying, “I wasn’t able to see the New Year’s Eve event, so I’ve really been looking forward to today!”
After the screening, visitors commented, “Seeing a giant Miku projected across the entire building was absolutely incredible. It felt like a completely new kind of live performance, and it went by so quickly that I didn’t want it to end,” and “My child loves Miku, so we came as a family, but the scale was beyond anything we imagined. Not only my child, but we parents ended up having just as much fun!”
Through this new show, visitors were able to experience the world of Hatsune Miku on a spectacular scale that can only be enjoyed at the Tokyo Metropolitan Government Building.
Overview
TITLE: HATSUNE MIKU LIGHTS TOKYO
HIGHLIGHT
The projection mapping show presented at the “Happy New Year Tokyo 2026” countdown event on New Year’s Eve 2025 returns with updated visual effects.
A giant Hatsune Miku appears across the facade of the Tokyo Metropolitan Government Building. Accompanied by her singing voice, her graceful dance and dazzling beams of light race up the building, illuminating the night in Shinjuku.
During the instrumental break, Hatsune Miku dives into a smartphone screen! Whether on the facade of the Tokyo Metropolitan Government Building or on your own smartphone, Hatsune Miku is always close at hand.
Now, Hatsune Miku, the virtual singer beloved around the world, takes center stage in one of the world’s largest projection mapping displays, presented on the Tokyo Metropolitan Government Building.
Music: SAWTOWNE / “M@GICAL☆CURE! LOVE ♥ SHOT!”
Planning and Direction: Masaru Yokoi
CG Direction and Production: Hidekazu Yagi
CG Production: Toshiyuki Hayashi, Erika Miyamae
Projection Design: Hitoshi Nakamura
Recording Studio: HANEDA xR STUDIO
Visual Production Support: TV Asahi Create Corporation, Ray
SHOWTIMES (August)
Weekends & Holidays: 7:00 p.m. / 9:00 p.m.
*Other projection mapping works will also be shown outside the times listed above.
*Please check the official website for the detailed screening schedule.
About “HATSUNE MIKU”
Hatsune Miku is a music software developed by Crypton Future Media, INC., which enables anyone to make their computer sing by entering lyrics and melodies. As a massive number of users created music using the software and posted their works on the Internet, Hatsune Miku quickly evolved into a cultural phenomenon. Since then, Hatsune Miku has gained much attention as a character, involved in many fields such as merchandising and live performance as a virtual singer. Now her popularity has spread across the globe.
Be Part of the Show with a Hatsune Miku Phone Wallpaper! Social Media Campaign |
TOKYO Night & Light is currently running a special campaign: everyone who comments on the designated post on the official Instagram account will receive an original image from HATSUNE MIKU LIGHTS TOKYO. This must-see campaign for fans allows visitors to feel as though they are part of the show while watching the projection mapping at the Tokyo Metropolitan Government Plaza. |
For details, please see the designated post on the official TOKYO Night & Light Instagram account. |
Campaign Period: July 15 (Wed) – August 21 (Fri) |
How to Participate: Comment on the designated post on the official TOKYO Night & Light Instagram |
account to receive an original image via direct message (DM). |
Campaign Images: Two original “HATSUNE MIKU LIGHTS TOKYO” images |
*One of the two images will be sent at random. You may enter the campaign as many times as you like. |
Official TOKYO Night & Light Instagram: https://www.instagram.com/tokyonightandlight/ |
Overview of the Tokyo Metropolitan Government Building Projection Mapping: "TOKYO Night & Light" | |
Dates: Daily (except during severe weather) | |
Projection Surface: East side wall of the | |
Tokyo Metropolitan Government Building No. 1 | |
Viewing Area: Tokyo Metropolitan Government Plaza | |
(2-8-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo) | |
Showtimes: 7:30 PM / 8:00 PM / 8:30 PM / 9:00 PM / 9:30 PM | |
(These times apply in August. For updated schedules, please visit the website.) | |
Organized by: Tokyo Metropolitan Government, | |
Tokyo Projection Mapping Executive Committee | |
Additional Information: This project is committed to environmentally friendly | |
practices, including the use of green energy. | |
It has been officially recognized by Guinness World Records™ as | |
“The Largest Permanent Projection Mapping Display on a Building” | |
TOKYO Night & Light has received the Travelers’ Choice Award 2026 from Tripadvisor, one of the world’s largest travel guidance platforms.
The award recognizes the top 10% of listings on Tripadvisor, selected from approximately 8 million listings worldwide based on traveler reviews and ratings.
This recognition further establishes TOKYO Night & Light as one of Tokyo’s leading tourist attractions.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260802298570/en/
Contacts
TOKYO Night & Light PR Office
(Managed by Jishaku Inc. – Contacts: Nagasawa, Endo, Hamasaki)
Email: pr@tokyo-night-and-light.jp
Phone: +81-80-3601-6732 (Nagasawa)
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 10:00:00 CEST | Press Release
Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphatax's long-term vision for the future of tax technology. By bringing these transfer pric
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 09:10:00 CEST | Press Release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
TOHKnet and Adtran conduct Japan’s first 50G PON trial on a live network4.8.2026 09:00:00 CEST | Press Release
Adtran today announced that TOHKnet has completed Japan’s first live network trial demonstrating the coexistence of 50G PON, XGS-PON and EPON on a single fiber. Conducted in Sendai using Adtran’s SDX 6400 Series OLT, the demo showed how the platform enables three generations of PON technology to operate together in a live service environment. The results highlight a realistic path for operators to introduce 50G PON capacity while maintaining continuity for existing services, maximizing the value of deployed fiber assets and reducing the complexity and disruption typically associated with network upgrades. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260803353435/en/ Adtran’s SDX 6400 Series is helping TOHKnet demonstrate how Japan’s operators can migrate to 50G PON without disrupting existing PON services. “As demand for digital services continues to grow, this trial is a key milestone for the future of fiber access in Jap
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 09:00:00 CEST | Press Release
Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 years, she has led global teams to achieve a 100% success rate from Phase 3 development through to FDA approval for multiple programs spanning oncology, immunology and respiratory medicine. In addition, she raised funds of around $400M as founder and CEO. Across her career she has contributed to 20 drug approvals, engaging
Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer4.8.2026 09:00:00 CEST | Press Release
Evexta Bio S.A., a precision oncology company, founded by Truffle Capital (founder of Abivax and Carvolix), and focused on the discovery and development of targeted therapies, today announced a clinical collaboration and supply agreement with plans to initiate a Phase 1b study combining its lead investigational compound, rupitasertib, with Roche’s investigational compound giredestrant, a selective estrogen receptor degrader (SERD), for the treatment of ER+, HER2-, ESR1-mutated advanced / metastatic breast cancer. Rupitasertib, is a first-in-class oral dual-node PI3K/AKT/mTOR (PAM) pathway inhibitor, which selectively inhibits S6K and AKT1/3. Rupitasertib was purposefully and rationally designed to target S6K for potent PAM inhibition and AKT1/3 to block the AKT compensatory feedback loop, while sparing AKT2 to avoid hyperglycemia, which we believe will lead to a superior efficacy and safety profile compared to other PAM pathway inhibitors. Under the terms of the agreement, Roche will s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom